Emerging

It’s not easy to get depression-detecting AI through the FDA: why this signal is getting harder to ignore

For the past seven years, the California-based startup Kintsugi has been developing AI designed to detect signs of depression and anxiety from a person’s speech. But after failing to secure FDA clearance in time, the company is shutting down and releasing most of its technology as open-source. This piece sits on 1 source layers, but the real value is showing why the story should not be skimmed past too quickly.

For the past seven years, the California-based startup Kintsugi has been developing AI designed to detect signs of depression and anxiety from a person’s speech. But after failing to secure FDA clearance in time, the company is shutting down and releasing most of its technology as open-source. The signal is strong enough to deserve attention, but it still needs to be read as something developing rather than fully settled.

Emerging The topic has initial corroboration, but the newsroom is still waiting on stronger confirmation.
Reference image for: It’s not easy to get depression-detecting AI through the FDA: why this signal is getting harder to ignore
Reference image from The Verge AI. The Verge AI

For the past seven years, the California-based startup Kintsugi has been developing AI designed to detect signs of depression and anxiety from a person’s speech. But after failing to secure FDA clearance in time, the company is shutting down and releasing most of its technology as open-source. Some elements may even find a second life beyond healthcare, like detecting deepfake audio. The Verge AI is the main source layer for now, and the rest should be read as a signal that is still widening. Changes like this often look small on screen while shifting product habits and day-to-day operating workflows much faster than expected.

Advertising slot

Patrick Tech Store Accounts, tools, and software now available in the store This slot is temporarily dedicated to the Patrick Tech ecosystem.

What is happening now

For the past seven years, the California-based startup Kintsugi has been developing AI designed to detect signs of depression and anxiety from a person’s speech. The main references behind this piece include The Verge AI.

Where the sources line up

The Verge AI is the main source layer for now, and the rest should be read as a signal that is still widening. But after failing to secure FDA clearance in time, the company is shutting down and releasing most of its technology as open-source. The main references behind this piece include The Verge AI.

Advertising slot

Patrick Tech Store Accounts, tools, and software now available in the store This slot is temporarily dedicated to the Patrick Tech ecosystem.

The details worth keeping

Some elements may even find a second life beyond healthcare, like detecting deepfake audio. Changes like this often look small on screen while shifting product habits and day-to-day operating workflows much faster than expected.

Why this matters most

The signal is strong enough to deserve attention, but it still needs to be read as something developing rather than fully settled. With 1 source layers on the table, the part worth reading most closely is where firm facts meet the market's early reaction. Mental health assessments still largely rely on patient questionnaires and clinical interviews, rather than the lab tests or scans common in physical medicine.

What to watch next

The next thing to watch is rollout speed, regional limits, and whether the update really changes day-to-day habits. Patrick Tech Media will keep checking rollout speed, user reaction, and how The Verge AI update the next pieces. In this pass, the story was distilled from 1 signals into 1 source references that are genuinely useful to readers.

Source notes

From Patrick Tech

Contextual tools

Related stories